PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsstomach neoplasms
MeSH D013274 - stomach neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D005770:Gastrointestinal neoplasms
$
Success rate
D013272:Stomach diseases
$
Success rate
D013274: 
Stomach neoplasms
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Accord HealthcareCapecitabine Capecitabine Accord  2012-04-20   
Docetaxel Docetaxel  2011-06-08   
Docetaxel Docetaxel Accord  2012-05-22   
Fluorouracil Fluorouracil  2007-04-26   
Mitomycin Mitomycin  1998-04-30   
Trastuzumab Zercepac  2020-07-27   
Cisplatin Cisplatin  2015-08-18   
Irinotecan Irinotecan  2008-11-21   
Methotrexate Methotrexate  2007-04-30   
Alembic PharmaceuticalsDocetaxel Docetaxel  2023-02-28   
Fluorouracil Fluorouracil  2023-03-03   
Methotrexate Methotrexate  2024-06-03   
AllerganDocetaxel Docetaxel  2013-04-12   
Irinotecan Irinotecan  2008-02-27   
American RegentFloxuridine Floxuridine  2017-11-22   
AmgenTrastuzumab Kanjinti  2018-05-16   
Amneal PharmaceuticalsDocetaxel Docetaxel  2018-01-19   
Methotrexate Methotrexate  2017-12-22   
ApotexDocetaxel Docetaxel  2012-01-11   
APP PharmaceuticalsFluorouracil Fluorouracil  1986-03-21   
Methotrexate Methotrexate  1985-10-11   
Astex PharmaceuticalsMitomycin Mitozytrex  2002-11-14   
AzurityMethotrexate Xatmep 2033-01-02 2017-04-25   
1
2
3
4
5
6
...
8
>
Clinical Trials
Historical Success Rate
Phase 1
74%
103/139
Phase 2
30%
57/192
Phase 3
41%
42/103
Approved: 16Overall Success rate: 9%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Accord Healthcare
Allergan
1
2
3
4
5
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use